Objectives: Innate immune dysfunction after major burn injuries increases the susceptibility to organ failure. Lipid mediators of inflammation resolution, e.g., resolvin D2, have been shown recently to restore neutrophil functionality and reduce mortality rate in a rat model of major burn injury. However, the physiological mechanisms responsible for the benefic activity of resolvin D2 are not well understood. Design: Prospective randomized animal investigation. Setting: Academic research setting. Subjects: Wistar male rats. Interventions: Animals were subjected to a full-thickness burn of 30% total body surface area. Two hours after burn, 25 ng/kg resolvin D2 was administered IV and repeated every day, for 8 days. At day 10 post burn, 2 mg/kg of lipopolysaccharide was administered IV, and the presence of renal and hepatic injuries was evaluated at day 11 post burn by histology, immunohistochemistry, and relevant blood chemistry. Measurements and Main Results: In untreated animals, we found significant tissue damage in the kidneys and liver, consistent with acute tubular necrosis and multifocal necrosis, and changes in blood chemistry, reflecting the deterioration of renal and hepatic functions. We detected less tissue damage and significantly lower values of blood urea nitrogen (26.4 ± 2.1 vs 36.0 ± 9.3 mg/dL; p ≤ 0.001), alanine aminotransferase (266.5 ± 295.2 vs 861.8 ± 813.7 U/L; p ≤ 0.01), and total bilirubin (0.13 ± 0.05 vs 0.30 ± 0.14 mg/dL; p ≤ 0.01) in resolvin D2-treated rats than in untreated animals. The mean blood pressure of all animals was above 65 mm Hg, indicating adequate tissue perfusion throughout the experiments. We measured significantly larger amounts of chromatin in the circulation of untreated than of resolvin D2-treated rats (575.1 ± 331.0 vs 264.1 ± 122.4 ng/mL; p ≤ 0.05) and identified neutrophil extracellular traps in kidney and liver tissues from untreated rats, consistent with the tissue damage. Conclusions: Pathologic changes in kidney and liver tissues in a rat model of major burn and endotoxin insults are ameliorated by resolvin D2. (Crit Care Med 2016; 44:e241-e252) 
one third of patients with major burn injury (1, 2) , a condition associated with a high mortality rate (3, 4) and often requires renal replacement therapy (5) . Changes in liver function and size are also common and could alter hepatic protein synthesis, acute-phase responses, and be followed by liver failure (6) (7) (8) . Thus, the prevention of AKI and liver dysfunction are critical treatment goals after major burns (1) . However, current treatment options are limited because multiple conditions contribute to organ failure and the mechanisms by which major burns could lead to organ failure are not well understood. Recent genomic data suggest a role for the dysfunctional innate immune reactions in multiorgan failure after major burns and trauma (9) . In particular, a central role for neutrophils, which represent the largest population of innate immune cells in the circulation, is emerging. The role of neutrophils is supported by experimental results, showing that removing neutrophils from the circulation before burn injury provides protection against organ damage in animal models. Several mechanisms by which excessive activation of neutrophils after burns is detrimental have been proposed (10) , more recently including the release of neutrophil extracellular traps (NETs) (11, 12) . In one recent study, we measured the neutrophil function with high precision over time, in a rat model of thermal injury and subsequent septic insult (13) . We observed that neutrophil motility was defective in the days after burn injury and found that these defects could be restored by lipid mediators of inflammation resolution. In particular, resolvin D2 (RvD2) (14) (15) (16) , when administered repeatedly after the injury, resulted in restored neutrophil speed and directionality and was correlated with improved survival in that model of burn and septic injury (13) . However, the mechanisms by which lipid mediators improve survival after burn injuries remain poorly understood.
To better understand how the lipid mediators contribute to improved survival during complications after major burns, we examined the pathology of kidney, liver, and other vital organs in a rat model of burn and endotoxin insult. We also investigated changes in hemodynamics, blood biochemistry, and tissue histology in response to RvD2 treatment. We identified NETs in tissues as a potential trigger for the secondary injury that occurs after major burns.
MATERIALS AND METHODS

Rat Model of Burn Injury
Wistar male rats, weighting 300-400 g (Charles River Laboratories, Wilmington, MA) were used in the experiments, after a 4-to 7-day acclimatization period. Rats were assigned randomly to eight study groups, which were subject to sham burn or burn procedures, with or without lipopolysaccharide (LPS), with or without RvD2 treatment. At least seven rats were included in each of the burn groups, and at least three in each of the sham burn groups. The procedure for thermal injury was performed as previously described (13) , with changes in the anesthesia protocol to reduce mortality after LPS injection. Specifically, before the experiments, rats were anesthetized with 50 mg/kg ketamine and 5 mg/kg xylazine intraperitoneally. Isoflurane 1-3% inhalant was added as needed. The fur of the dorsal surface was shaved, and rats were placed in a mold exposing 30% of total body surface area to precisely control the area of burn injury. The exposed area was immersed in boiling water for 12 seconds, producing a full-thickness burn. Rats in the sham burn groups followed the same procedure but were exposed to water at room temperature. Immediately after burn or sham burn injury, all rats received fluid resuscitation with 40 mL/kg of normal saline intraperitoneally. All rats were kept on a thermostat water blanket until recovery from anesthesia, when they were moved into individual cages. Buprenorphine at a dose of 0.05 mg/kg was injected subcutaneously before the anesthesia and continued every 12 hours in the first 48 hours after this procedure. All procedures were conducted using aseptic techniques. All animal protocols were approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital.
Secondary Endotoxin Insult and Study Endpoint
Rats were injected with 2 mg/kg of the LPS derived from Escherichia coli 0111:B4 (Sigma-Aldrich, St. Louis, MO) via tail vein at day 10 post burn (day 10 pb) or sham burn. Vehicle solution (0.9% saline) was injected to control rats. After the LPS injection, all rats were monitored closely for 24 hours, after which they were euthanized.
RvD2 Treatment
RvD2 (Cayman Chemical, Ann Arbor, MI) was administered starting at 2 hours after the burn procedure, every day, for 8 days (day 0 pb to day 7 pb), as previously described in detail (13) . Twenty-five nanogram per kilogram of RvD2 in 0.3% ethanol was administrated via tail vein injection. Vehicle (0.3% ethanol) was administered to control rats. After restraining the rats with appropriate size devices, the tail was placed in warm (30-35°C) water for 3 minutes to dilate the veins. A 25 G needle attached to a 1-mL syringe filled with 500 µL/kg of RvD2 or vehicle was inserted to the tail vein and the solution injected slowly. The rats were released from the restraint as soon as the bleeding stopped.
Blood Collection and Measurement
To measure blood chemistry, the blood was drawn from the tail vein at three time points: before the burn procedure (day 0 pb), before the LPS injection (day 10 pb), and 24 hours after injecting LPS (day 11 pb). Blood chemistry was analyzed at the Center for Comparative Medicine veterinary clinical pathology laboratory of Massachusetts General Hospital. To measure plasma genomic DNA levels, additional blood samples were collected at the end of the study using sodium citrate as anticoagulant. The blood samples were immediately processed by centrifugation (1500g × 10 min, 4°C) to isolate plasma, which was quickly stored at -80°C. Plasma genomic DNA was measured using a commercially available diagnostic kit, Quant-iT PicoGreen double-strand DNA assay kit (Invitrogen, Eugene, OR). Twenty-four hours after LPS injection, all rats were euthanized with 200 mg/kg of sodium pentobarbital IV, and tissue samples were collected for analysis (day 11 pb).
Noninvasive Hemodynamic Measurement
To monitor the hemodynamic state of the rats after burn injury, we measured their blood pressure and pulse rate (PR) using a noninvasive tail cuff method (CODA2; Kent Scientific, Torrington, CT). Measurements were performed at day 0 (before the injury), at day 10 pb, before the LPS injection, and then at 12 hours (day 10.5 pb) and 24 hours (day 11 pb) after the LPS injection. During the procedure, which was usually completed in less than 10 minutes, rats were restrained and kept on a thermostat water blanket. To reduce the potential for artifacts due to stress during animal restraint, rats were briefly anesthetized using 1-2% isoflurane. To reduce the potential for cross infections, the restraining device was cleaned thoroughly after each measurement.
Tissue Histology
To examine the histology of kidney and liver after injury, tissues were harvested at day 11 pb and fixed in 10 % phosphate buffered formalin. Paraffin-embedded tissues were sliced into 4-µm sections and stained with hematoxylin and eosin. To quantify kidney injury, we used a semiquantitative score for renal tubular injury as described (17) , which is commonly used for assessing kidney injury in murine septic models (18, 19) . Briefly, two trained observers, blinded to the experimental conditions, analyzed each slide and evaluated the extent of tubular pathology, including the presence of tubular casts, tubular dilatation/flattening, and tubular degeneration/vacuolization. The observers assigned a score graded from 0 (normal, < 5% tubules altered, in three random microscopy fields), 1 (mild, 5-33%), 2 (moderate, 34-66%), to 3 (severe, > 66%). We used a similar scale for evaluating liver tissue sections, for which we quantified the extent of degeneration or edematous changes of hepatocytes, infiltration of inflammatory cells in the portal area, and spotty necrosis, as previously described (20, 21) .
Immunohistology for Megalin Expression in the Proximal Tubules
Kidney sections were deparaffinized by two changes of xylene (5 min each) and washed with descending concentrations of ethanol (100% × 2, 90%, 70%, 50%, 30%, 5 min each wash) before transferring the sections to PBS. Sections were washed in PBS for 15 minutes, treated with 1% SDS (4 min) for antigen retrieval (22) , washed with PBS (3 × 5 min), and blocked with 1% bovine serum albumin for 30 minutes. Primary antibody against megalin (rabbit-polyclonal; a generous gift from Dr. Daniel Biemesderfer, Yale University School of Medicine) was diluted in DAKO antibody diluent (DAKO, Carpinteria, CA) and applied to the tissue overnight at 4°C. Following incubation, tissues were washed with PBS (3 × 5 min). Secondary antibody raised in goat, conjugated with alexa fluor 488 (Jackson Immuno Research Laboratories, West Grove, PA), was diluted in DAKO (1:200) before applying for 45 minutes at room temperature. Slides were cover-slipped using Vectashield (Vector Laboratories, Burlingame, CA) and analyzed using a Nikon A1R confocal microscope. For quantification, the mean intensity of each tubular region was measured using NIS Elements software (Nikon). For this, five proximal tubules per image were outlined manually, in three images per animal (i.e., ≈15 tubules per animal), and the mean fluorescence intensity of the outlined area was determined for each tubule. An average intensity was calculated for all images from the same animal and then for all the animals in the same group.
Immunohistochemistry for NETs
To study the NETs in tissues, we relied on immunohistochemistry. After de-waxing, the tissues were washed with Tris-buffered saline (Abcam, Cambridge, MA) (3 × 5 min) and blocked with 1% bovine serum albumin for 1 hour. Each tissue was stained with PL2-6 antibodies (specific for histone and DNA) (23, 24) . To improve the performance of the antibodies and signal to background ratios, we used both ultrasensitive avidin-biotinperoxidase complex mouse IgG staining kit (Thermo Scientific, Rockford, IL) and the tyramide signal amplification (TSA), using the TSA plus cyanine 3 kit (PerkinElmer, Waltham, MA). TSA reagent was diluted 1:50 in TSA diluent. To further verify the neutrophil origin of the detected extracellular chromatin, we performed double staining, using Anti-Neutrophil Elastase Antibody (Abcam) and Goat Anti-Rabbit IgG H&L Alexa Flour 488 antibody (Abcam). Slides were mounted the slides using Vectashield HardSet mounting medium (Vector Laboratories).
Statistical Analysis
Experimental data were expressed as mean and sd of the mean. The number of animals in each experiment and number of experimental repeats are presented in figure captions. Statistical tests performed include one-way analysis of variance, two-way analysis of variance with repeated measure, and multiple-comparison tests. Differences were determined to be significant for p values of less than or equal to 0.05 (in the figures *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
RESULTS
RvD2 Treatment Improves Survival at 24 Hours, After Burn, and Endotoxin
We monitored and treated the animals in the burn and sham burn groups for up to 11 days ( Fig. 1A) . Two animals in the burn untreated group (20%) died within 24 hours after the second septic insult (n = 10 rats, n = 7 experiments). All animals in the burn and RvD2 treatment groups (n = 7 rats, n = 4 experiments), as well as sham burn-treated (n = 3 rats, n = 2 experiments) and untreated groups (n = 3 rats, n = 3 experiments), survived over 24 hours after LPS injection. The survival rate in the current experiments was higher than in our previous experiments (13) , likely due to optimization of the general anesthesia protocol in this study. However, the rapid deterioration of health and subsequent death in less than 24 hours prompted us to consider the possibility that one or more vital organs was being affected in this double insult model.
RvD2 Treatment Reduces Secondary Organ Injury After Burn and Endotoxin
We identified pathologic changes in the kidneys of rats with burn injury. These changes included the presence of casts, tubular dilatation, and ballooning degeneration of proximal tubules in the renal cortex and were more significant in animals receiving LPS than the other burn groups (Fig. 1, B and  C) . Kidneys from rats treated with RvD2 after burn and LPS injection displayed significantly fewer pathological changes than the untreated rats ( Fig. 1D) . We measured significant reductions in proximal tubules cast formation, tubular dilatation, and ballooning degeneration (p ≤ 0.01, ns, and p ≤ 0.05, respectively, n = 6 rats, n = 3-4 experiments), indicating that RvD2 treatment attenuates tubular injuries ( Fig. 1,  E-G) . The pathologic changes in the kidney, in the burn-only group, and sham burn with LPS injection group were also ameliorated by RvD2 treatment. We did not find signs of tissue Figure 1 . Timeline of the burn injuries, treatment, and renal cortex injury. A, Blood samples were collected before the burn procedure (day 0), before injecting lipopolysaccharide (LPS; day 10 post burn [pb]), and 24 hr after LPS (day 11 pb). Hemodynamic measurements were also performed at the same time points. One additional measurement was performed at 12 hr after LPS injection. For animals receiving treatment, 25 ng/kg of resolvin D2 (RvD2) were administered first at 2 hr after burn injury (day 0) and continued daily until day 7 after burn. B and C, Representative section of renal cortex at day 11 pb, in burn and LPS, untreated group. Tubular injuries were observed, including tubular cast formation (arrows), and ballooning degeneration/ vacuolization of renal proximal tubular cells (hematoxylin and eosin [H&E], ×400; scale bar, 50 µm). D, Light microscopic image at day 11 pb in burn and LPS, RvD2-treated group, indicated that tubular injury was reduced by RvD2 treatment in renal cortex (H&E, ×400; scale bar, 50 µm). E-G, Quantitative analysis of pathologic changes in the renal cortex (n = 3 rats total, n = 2-3 experiments for each sham burn group; n = 6 rats total, n = 3-4 experiments for each burn group). We used semiquantitative scores (from 0 [normal] to 3 [severe]), as previously described [17] ). We assessed the presence of tubular casts, tubular dilatation/flattening, and tubular degeneration/vacuolization in the renal cortex. In all comparisons, RvD2 treatment reduced the pathologic changes of tubular cells in renal cortex (burn/LPS vs burn/LPS/RvD2; **p ≤ 0.01, ns, and *p ≤ 0.05, respectively).
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Main pathologic changes in the liver were in the form of hepatic tissue necrosis and infiltration of inflammatory cells in the periportal area. These changes were observed with the highest frequency in the burn and LPS groups ( Fig. 2A) . The diffuse necrosis occurred in almost 50% of the hepatocytes in the burn and LPS groups. The injury was significantly diminished in the RvD2-treated group (p ≤ 0.001, n = 6 rats, n = 3-4 experiments) (Fig. 2, B and C) . Ballooning degeneration or edematous changes occurred predominantly in rats with burns and LPS and were suppressed in the RvD2-treated group (p ≤ 0.05, n = 6 rats, n = 3-4 experiments) ( Fig. 2D) . Neither the burn injury alone nor the LPS alone resulted in significant necrotic damage of the liver tissue. Pathologic change scores for the kidney and hepatic tissue damages were similar in burn-only group and the LPS injection in sham burn group. We did not observe any significant pathologic changes in lung tissues from rats with burns and LPS when compared those in healthy controls (data not shown).
Hemodynamic Changes in Burn Groups
Recent studies suggested that AKI could develop despite adequate resuscitation after burn injury (2) . To verify that the kidney and liver pathologies seen after burn and LPS are not secondary of hemodynamic changes, we measured blood pressure and PR before and after the two injuries.
The systolic blood pressure decreased on average by 20% in untreated animals after injecting LPS (day 10.5 pb and day 11 pb) when compared with their blood pressure before burns (day 0) and before endotoxin (day 10 pb) ( Fig. 3D) . We found significant differences between untreated and treated groups after injecting LPS, at day 10.5 pb (systolic blood pressure, 96.5 ± 8.1 vs 117.0 ± 19.5 mm Hg, p ≤ 0.05; mean blood pressure, 75.3 ± 5.5 vs 94.0 ± 19.9 mm Hg, p ≤ 0.05, n = 6 rats, n = 3-4 experiments). However, the mean blood pressure was over 65 mm Hg throughout the study in all groups, suggesting that organ perfusion was adequate throughout the experiment (Fig. 3, E and F) . Furthermore, the PR was significantly higher after the injection of LPS in the burn and LPS group (538 ± 130 bpm, n = 6 rats, n = 4 experiments) than in the RvD2-treated group (460 ± 120 bpm, p ≤ 0.05, n = 6 rats n = 3 experiments) ( Fig. 3H) . In the sham burn group, the measurements did not show any significant hemodynamic changes throughout this study ( Fig. 3, C, E, and G) .
Body Weight Changes
Burn group rats lost 5% of body weight in the first 3 days after the 30% total body surface area burn injury and recovered by day 10 pb (Fig. 3B) . Rats in sham burn groups also lost their weight, likely . Burned rats (all) lost about 5% of total body weight in the 3 or 4 d post burn injury and recovered at 10 days after burn. The body weight loss was comparable in treated and untreated groups (orange and green lines). After lipopolysaccharide (LPS) injection, both resolvin D2 (RvD2)-treated (blue) and untreated (red) groups showed comparable body weight loss. C-F, Systolic and mean blood pressure (SBP and MBP, respectively) in sham burn (C and E) and burn groups (D and F). We monitored hemodynamic changes using noninvasive tail cuff measurement at four points, day 0 (pre burn), day 10 pb (before LPS), and then at 12 (day 10.5 pb) and 24 (day 11 pb) hr after the LPS injection. After LPS, the SBP and the MBP decreased slightly in untreated groups. Differences between untreated and treated rats were significant at 12 hr after LPS (burn/LPS vs burn/LPS/RvD2; *p ≤ 0.05). It is important to note that MBP was maintained above 65 mm Hg for all animals throughout the study. G and H, Pulse rate (PR) increased after LPS, more in untreated than in RvD2-treated group (H). The difference between untreated and treated animals increased at 24 hr after endotoxin in burn and LPS groups (burn/LPS vs burn/LPS/RvD2; *p ≤ 0.05). Hemodynamic condition, including SBP, MBP, and PR, did not change significantly in all sham burn groups (A-H, n = 3 rats total, n = 2-3 experiments for each sham burn group; n = 6 rats total, n = 3-4 experiments for each burn group).
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Blood Chemistry Changes After Burn and Endotoxin Are Ameliorated by RvD2 Treatment
To probe the systemic effect of the pathological changes in the kidney, we compared blood urea nitrogen (BUN) and serum creatinine at three points, day 0 (before burn), day 10 pb (pre injecting LPS), and day 11 pb (24 hr after injecting LPS). BUN in rats with burns increased after LPS injection (Fig. 4B) , and the increase was significantly more prominent in the nontreatment group (36.0 ± 9.3 mg/dL, n = 6 rats, n = 4 experiments) than in RvD2-treated group (26.4 ± 2.1 mg/dL, p ≤ 0.001, n = 6 rats, n = 3 experiments). Interestingly, BUN in sham burn rats increased after LPS injection (Fig. 4A) . However, in all groups, serum creatinine values did not change significantly in the 24 hours after the injection of LPS (Fig. 4, C and D) . Serum albumin values were significantly lower in both severe burn and second septic insult untreated groups than in the RvD2treated rats ( †burn vs burn/RvD2, 2.7 ± 0.2 vs 2.9 ± 0.1 g/dL, p ≤ 0.05; *burn/LPS vs burn/LPS/RvD2, 2.4 ± 0.3 vs 2.7 ± 0.2 g/ dL, p ≤ 0.05, n = 6 rats, n = 3-4 experiments) (Fig. 4F) . In sham burn groups, levels of serum albumin were preserved during the treatment period and decreased sharply after LPS injection (Fig. 4E) . These changes are consistent with dysfunction of kidney (filtration or reabsorption) and liver (synthesis). They are unlikely to represent losses at the wound site, which was maintained dry throughout the experiments. Overall, the RvD2 treatment prevented the deterioration of blood chemistry relevant to renal and hepatic functions after major burns and LPS injection.
To probe the systemic effect of the pathological changes in the liver, blood biochemistry relevant to liver function was also monitored along the course of experiment. We compared alanine aminotransferase (ALT), alkaline phosphatase (ALP), total bilirubin, and glucose levels at three points, day 0 (before burn), day 10 pb (pre injecting LPS), and day 11 pb (24 hours after injecting LPS). Serum ALT and ALP values increased after injecting LPS in the burn without treatment group when compared with those in the treated group (ALT: 861.8 ± 813.7 vs 266.5 ± 295.2 U/L, p ≤ 0.01; ALP: 604.2 ± 190.0 vs 378.2 ± 135.9 U/L, p ≤ 0.001, n = 6 rats, n = 3-4 experiments) (Fig. 5, A and B) . Serum total bilirubin values, which are used for evaluating multiple organ failure in Sequential Organ Failure Assessment score (25) and multiple organ dysfunction score (26) , increased significantly after injecting LPS in the untreated group (0.30 ± 0.14 mg/dL, n = 6 rats, n = 4 experiments) when compared with those in the RvD2treated group (0.13 ± 0.05 mg/ dL, p ≤ 0.01, n = 6 rats, n = 3 experiments) ( Fig. 5C) . Interestingly, we also found that in the untreated group, blood glucose values decreased significantly after injecting LPS (49.3 ± 43.9 mg/dL, n = 6 rats, n = 4 experiments), but remained close to normal in the corresponding RvD2treated group (97.3 ± 11.2 mg/ dL, p ≤ 0.01, n = 6 rats, n = 3 experiments) ( Fig. 5D ).
Megalin Expression Levels in the Proximal Tubules
We stained proximal tubules for megalin, a 600-kDa transmembrane receptor protein that is involved in the proximal tubular reabsorption of proteins, hormones, and other components of the glomerular ultrafiltrate (27) . We quantified megalin expression levels and found reduced expression after burn injury when compared with sham burn rats. Levels of megalin expression after burn injury retuned to control values in the RvD2-treated group (Fig. 4, G and H) . These results are consistent with a reduction of reabsorbing function in proximal tubules after severe burn injury. However, we did not detect any differences in the burn and endotoxin groups, regardless of RvD2 treatment (Fig. 4, I) . This is consistent with previous reports that LPS can act directly on the rat proximal tubular cells and directly alter the expression of megalin (28) .
Plasma Genomic DNA Values After Burn and Endotoxin Are Lower in the RvD2-Treated Rats
To investigate the possible mechanisms responsible for the observed pathology, we focused on the release of NETs from overly activated neutrophils. We measured the changes in the plasma levels of genomic DNA and found lower values at day 0 before burn procedure (average, 83.9 ± 31.5 ng/mL) than at 6 hours post burn injury (565.5 ± 213.5 ng/mL, n = 2 rats). Plasma DNA levels decreased to 254.6 ± 110.9 ng/mL (n = 6 rats) at day 11 pb in the burn untreated group (n = 19 rats) ( Fig. 6A) . RvD2 treatment suppressed the early increase in the burn-only group (188.7 ± 59.6 ng/mL, ns, n = 6 rats, n = 4 
The Amount of NETs Present in the Kidney and Liver After Burn and Endotoxin Is Reduced in RvD2-Treated Animals
In the burn and LPS without treatment groups, we identified extracellular histone/DNA complexes (by the PL2-6 antibody) in the renal cortex, outside of the proximal tubular cells (Fig. 6B) . These are likely to be derived from neutrophils, based on the colocalization of neutrophil elastase and chromatin. The area of tissue occupied by the NETs in the cortex was significantly greater in the untreated than in the RvD2-treated animals with burn and LPS insults. In liver tissue, we found high fluorescence intensity corresponding to the presence of NETs between hepatocytes ( Fig. 6C) . Furthermore, we could find the large amounts of neutrophil elastase colocalized in the necrosis area (Fig. 6D) . The accumulation of NETs in the liver was significantly reduced in the RvD2 treatment group when compared with the nontreatment group and correlated with lower amount of liver tissue damage.
DISCUSSION
In this study, we show that RvD2 can ameliorate kidney and liver injury in a rat model that combines major burn and LPS insults. Using this model, we document the presence of histological changes in the renal cortex and liver and measure the deterioration of blood chemistry reflecting the acute dysfunction of these organs. We found that the burn injury and LPS together have a synergistic effect on distant tissue damage, which appears to be larger than either one insult alone. For example, we observed significant damage to the liver in the double-hit model, whereas neither the burn injury nor the LPS alone result significant necrotic damage in liver. We demonstrate that these changes could be prevented by the administration of RvD2 starting at 2 hours after burn injury, once a day for more than 1 week. The RvD2 treatment is most potent in the double-hit model, when RvD2 administered in the time between the thermal injury and the LPS insult appears to be disrupting the synergy between the two insults.
LPS injection is a common model for the study of innate immune response during infections and serves as a surrogate for an infection with gram negative bacteria (29) . The features of this model are relevant to the common clinical situation when an infection develops in patients with major burn injury. The LPS injection model is useful for stimulating systemic innate immune responses (30) and avoids the local complications and variability of using live microbes. Furthermore, in one recent study, LPS injection and Cecum Ligation procedures yielded comparable survival trends and cytokine levels . NETs appear to be located outside of proximal tubular cells in the renal cortex. Scale bar, 10 µm. C, Immunohistochemistry section of hepatic tissues at day 11 pb in burn and LPS groups. High fluorescence intensity, corresponding to the presence of NETs, can be observed outside of the hepatocyte in burn and LPS without treatment groups. Scale bar, 10 µm. D, Representative section of hepatic focal necrosis at day 11 pb in burn and LPS groups (immunohistochemistry). High fluorescence intensity of histone/DNA and elastase, corresponding to large amounts of NETs, can be observed at area of necrosis. Scale bar, 10 µm.
after burn injury (13) . Consequently, in this study, we used LPS for the second septic insult after major burn.
Several studies have demonstrated the restorative ability of resolvins in various other conditions besides burns (13, 31) , including sepsis (32), inflammatory pain (33), colitis (34) , ischemic kidney injury (14) , vascular injury (35), etc. A common denominator for these actions was the restoration of neutrophil functionality (15, 16) and innate immune homeostasis (14) (15) (16) (31) (32) (33) (34) (35) (36) (37) (38) . Consistent with previous studies, the dose of RvD2 administration in this study was based on previous optimizations of the amount, duration, and types of resolvin that restore neutrophil functionality (13) . It is important to emphasize that one of the implications of restored neutrophil activity is better protection against infections and that RvD2 was reported to enhance the antibacterial function in neutrophils (13, 32) . Furthermore, long-term studies involving RvD2 administration have been reported in some disease models (33, 35) , suggesting that the beneficial effect on neutrophils could be maintained over time. Interestingly, the amount of RvD2 involved in this study is in the nanogram range, suggesting that the compound may be acting on specific targets, yet to be identified (39) (40) (41) . Together, the results of current and previous studies converge toward RvD2 being an ideal candidate for the restoration of immune system responses in the context of the systemic inflammatory responses after major burns (42) (43) (44) .
Our histology findings suggest that chromatin derived from neutrophils as NETs may contribute to the complications of vital organ dysfunction after major burn. Overly active neutrophils have been proposed as potential link between the systemic inflammation and the secondary organ injury after major burns, supported by genomic (45) and functional measurements (46) . Overactivated neutrophils can release their chromatin as NETs (12, (47) (48) (49) (50) (51) and can lead to significant tissue damage (52) (e.g., in cystic fibrosis [53] , lupus and associated nephritis [54] , or acute respiratory distress syndrome [55] ). Higher concentrations of chromatin in the circulation have been previously documented in burn and other critically ill patients (56) (57) (58) (59) , supporting the relevance of our model for human disease. Previous studies have suggested that the presence of myeloperoxidase and elastase in tissues may be responsible for organ and tissue damages (60) . Our finding that RvD2 treatment reduces the amount of NETs in vital organs provides new support for a mechanism involving the overactivation of neutrophils. This possibility is further substantiated by the beneficial effects of the normalization of neutrophil functionality by RvD2 after burn and endotoxin insults, measured previously using microfluidic devices (13) . Future studies to understand the mechanisms by which RvD2 reduces the release of NETs may help develop effective therapies to reduce kidney and liver dysfunction in burn patients.
One more unexpected result from our study is the finding that RvD2 treatment could prevent the lower glycemia levels, which would otherwise occur after LPS injection. Hypermetabolism is a prominent feature of major burn injury, with two-fold increases in resting energy expenditure and a more than 50% increase in gluconeogenesis (61) . Part of the beneficial effect of RvD2 treatment could be explained by the reduction in damage to liver tissue, but other mechanisms may be involved as well (62) . One example is the reductions of the stress and pain in the treated group, a possibility that will require further investigation.
The relevance of our findings from the animal models to patients is worth discussing in light of recent analysis in humans, which has documented the presence of significant levels of endogenously produced RvD2 in healthy individuals (63) . Furthermore, recent studies in trauma patients suggest that higher resolvin pathway gene expression levels and lower gene expression ratios of leukotriene:resolvin pathways in human patients correlate with less complications after trauma (64) . Together, the previous studies and current findings converge on the possibility that neutrophils participate in the distal tissues damage. They also raise the possibility that new therapies involving the lipid mediators of inflammation resolution, which showed benefit in relevant animal models (13, 31, 32, 65) , could eventually be effective in patients after major burn or trauma injuries.
In conclusion, our study shows that the beneficial effect of RvD2 after burns and endotoxin insults could be explained by the prevention of acute kidney and liver injuries, likely mediated by reduced accumulation of NETs in kidney and liver.
